Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells

Journal of Neurochemistry

Volumn 67, Issue 1, 1996, Pages 212-219

  Robinson, Susan W ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Adenylyl cyclase; Chimeric proteins; Dopamine D2 receptor; HEK 293 cells

Indexed keywords

ADENYLATE CYCLASE; CHIMERIC PROTEIN; CYCLIC AMP; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; PROSTAGLANDIN E1; QUINPIROLE; HYBRID PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; KIDNEY; METABOLISM; PHYSIOLOGY;

ADENYLATE CYCLASE; CELL LINE; CYCLIC AMP; HUMANS; KIDNEY; PROTEIN CONFORMATION; RECEPTORS, DOPAMINE D2; RECOMBINANT FUSION PROTEINS;

EID: 0029666441     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67010212.x     Document Type: Article

References (39)

1. Andersson S., Davis D. L., Dahlbäck H., Jörnvall H., and Russell D. W. (1989) Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264, 8222-8229.
2. 2 receptor mRNA. Brain Res. 564, 203-219.
3. 3 receptors to G-proteins. FEBS Lett. 315, 223-226.
4. Chazenbalk G. D., Nagayama Y., Russo D., Wadsworth H. L., and Rapoport B. (1990) Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J. Biol. Chem. 265, 20970-20975.
5. 2 dopamine receptors. Mol. Pharmacol. 45, 51-60.
6. Chio C. L., Drong R. F., Riley D. T., Gill G. S., Slightom J. L., and Huff R. M. (1994b) D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J. Biol. Chem. 269, 11813-11819.
7. Civelli O., Bunzow J. R., and Grandy D. K. (1993) Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. 32, 281-307.
8. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. USA 87, 2896-2900.
9. Cullen B. R. (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152, 684-704.
10. 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. J. Biol. Chem. 266, 11025-11029.
11. Dixon R. A. F., Sigal I. S., Rands E., Register R. B., Candelore M. R., Blake A. D., and Strader C. D. (1987) Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core. Nature 326, 73-77.
12. Franke R. R., Sakmar T. P., Oprian D. D., and Khorana H. G. (1988) A single amino acid substitution in rhodopsin (lysine 248→leucine) prevents activation of transducin. J. Biol. Chem. 263, 2119-2122.
13. Franke R. R., König B., Sakmar T. P., Khorana H. G., and Hofmann K. P. (1990) Rhodopsin mutants that bind but fail to activate transducin. Science 250, 123-125.
14. 3 dopamine receptor. J. Pharmacol. Exp. Ther. 268, 417-426.
15. Gingrich J. A. and Caron M. G. (1993) Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16, 299-321.
16. 3 humain et identification de son chromosome. C. R. Acad. Sci. [III] 311, 501-508.
17. Hedin K. E., Duerson K., and Clapham D. E. (1993) Specificity of receptor-G protein interactions: searching for the structure behind the signal. Cell. Signal. 5, 505-518.
18. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240, 1310-1316.
19. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5, 145-153.
20. Lefkowitz R. J., Samama P., Cotecchia S., and Costa T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14, 303-308.
21. 3 receptor expressed in transfected cell lines. Eur. J. Pharmacol. 266, 79-85.
22. 2 dopamine receptor expressed in CHO cells. FEBS Lett. 324, 81-86.
23. 4 dopamine receptors in HEK293 cells. J. Recept. Signal Transduction Res. 15, 267-281.
24. Neer E. J. (1995) Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80, 249-257.
25. 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J. Biol. Chem. 263, 15985-15992.
26. Ohyama K., Yamano Y., Chaki S., Kondo T., and Inagami T. (1992) Domains for G-protein coupling in angiotensin II receptor type I: studies by site-directed mutagenesis. Biochem. Biophys. Res. Commun. 189, 677-683.
27. 3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur. J. Pharmacol. 268, 129-139.
28. 3 dopamine receptors. J. Neurosci. 14, 1463-1476.
29. 3 receptor: chimeric receptors delineate a role for intracellulai domains. Mol. Pharmacol. 46, 352-356.
30. 3H]cAMP in cell monolayers, cell suspensions, and tissue slices. Methods Enzymol. 195, 22-28.
31. Savarese T. M. and Fraser C. M. (1992) In vitro mutagenesis and the search for structure-function relationships among G proteincoupled receptors. Biochem. J. 283, 1-19.
32. 3 dopamine receptors in differentiated neuroblastoma × glioma NG108-15 cells. Br. J. Pharmacol. 111, 391-393.
33. 2 (short) dopamine receptors expressed in differentiated NG108-15 cells. Br. J. Pharmacol. 111, 1061-1066.
34. 3) as a target for neuroleptics. Nature 347, 146-151.
35. 2 receptor. Eur. J. Pharmacol. 225, 331-337.
36. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268, 495-502.
37. 3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270, 475-479.
38. Van Leeuwen D. H., Eisenstein J., O'Malley K., and MacKenzie R. G. (1995) Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells. Mol. Pharmacol. 48, 344-351.
39. Wess J., Bonner T. I., Dörje F., and Brann M. R. (1990) Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol. Pharmacol. 38, 517-523.